RETNLB and colonic neoplasm: Interestingly, we found that no report reported the RETNLA expression or function in cancers, but as early as a decade ago, positive RETNLB expression had been tested in 81.25% of 80 colon cancer patients, where there was a positively correlation between RETNLB expression and survival time [14].